Von Eschenbach Andrew C. insider trades
Von Eschenbach Andrew C. has filed 19 Form 4s with the SEC that we hold, for Bausch & Lomb Corp (BLCO) (Director), Celularity Inc (CELU) (Director), TriSalus Life Sciences, Inc. (TLSI) (Director) and RDUS (Director), among 5 companies in all. Across all of them we count 3 purchases worth $136.2K and 2 sales worth $306.7K reported on Form 4. In the last 12 months: 1 purchase ($79.9K) and 2 sales ($306.7K). The largest single trade was a sale of 12,500 shares of Bausch & Lomb Corp worth $206.2K, dated 2026-08-06. The first filing on our record is dated 2021-07-20 and the latest 2026-08-10.
Bausch & Lomb Corp (BLCO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-05-02 | P, purchase reported on Form 4 | 1,695 | $19.9K | 2025-05-06 |
| 2026-02-27 | P, purchase reported on Form 4 | 4,364 | $79.9K | 2026-03-03 |
| 2026-08-06 | S, sale reported on Form 4 | 12,500 | $206.2K | 2026-08-10 |
| 2026-08-07 | S, sale reported on Form 4 | 6,059 | $100.5K | 2026-08-10 |
Celularity Inc (CELU)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
TriSalus Life Sciences, Inc. (TLSI)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
RDUS
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Bausch Health Companies Inc. (BHC)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-05 | P, purchase reported on Form 4 | 1,400 | $36.3K | 2021-08-09 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1536529) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms